Home › Asthma › Texas › Austin
Asthma clinical trials in Austin, TX
4 studies for Asthma are looking for participants at sites in and around Austin (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
RecruitingPhase 3
- Research Site, Austin
A Study to Learn About the Study Medicine Called Tilrekimig ( PF-07275315) in People With Severe Asthma
RecruitingPhase 3
- Orion Clinical Research, Austin
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
RecruitingPhase 2
- Research Site, Austin
Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects
RecruitingObservational study
- Orion Clinical Research, Austin
About Asthma
Asthma is a chronic lung disease. It causes asthma attacks, which make your airways inflamed and narrowed, and your lungs get less air. Learn about treatments.
More about Asthma on MedlinePlus
Asthma trials in other cities
- Miami, FL13 studies
- New York City, NY11 studies
- Boston, MA11 studies
- The Bronx, NY10 studies
- Dallas, TX10 studies
- Houston, TX9 studies
- Kansas City, KS9 studies
- Durham, NC9 studies
- St. Louis, MO9 studies
- Oklahoma City, OK9 studies
- Washington, DC9 studies
- Charlotte, NC7 studies
Other studies in Austin
- Non-Small Cell Lung Cancer29 studies
- Cancer (all types)22 studies
- Obesity22 studies
- Overweight19 studies
- Metastatic Cancer18 studies
- Colorectal Cancer17 studies
- Ovarian Cancer17 studies
- Heart Failure17 studies
- Endometrial Cancer15 studies
- Breast Cancer15 studies
- Type 2 Diabetes14 studies
- Prostate Cancer14 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.